- #741858
- Sanofi Pasteur #00024582411
Jevtana® Cabazitaxel 60 mg / 1.5 mL Intravenous Injection Single Dose Vial 1.5 mL
JEVTANA INJ+DIL, SDV 60MG/1.5 ML 1.5ML

Features
- JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen
- JEVTANA is supplied as a kit containing one single-use vial of JEVTANA (cabazitaxel) Injection (clear glass vial with a grey rubber closure, aluminum cap and light green plastic flip-off cap) and one vial of Diluent for JEVTANA (13% (w/w) ethanol in water for injection) in a clear glass vial with a grey rubber closure, gold-color aluminum cap and colorless plastic flip-off cap
- JEVTANA requires two dilutions prior to administration
- More …
Professionals Also Viewed

- #479124
-
224
- APP Pharmaceuticals #63323011710
Fluorouracil 50 mg / mL Intravenous Injection Single Dose Vial 10 mL
- #479124
- 224
- APP Pharmaceuticals #63323011710

- #788329
-
203
- Fresenius USA #63323011751
Fluorouracil 50 mg / mL Intravenous Injection Pharmacy Bulk Vial 50 mL
- #788329
- 203
- Fresenius USA #63323011751

- #652633
-
151
- Fresenius USA #63323012310
Methotrexate Sodium 25 mg / mL Intramuscular, Intravenous, or Intra-arterial Injection Multiple Dose Vial 10 mL
- #652633
- 151
- Fresenius USA #63323012310
- Contains preservative
- Sterile Isotonic Liquid
- Not for intrathecal use
No Image
- #1129996
-
124
- North Star Rx #16714088601
15 Units Injection Single Dose Vial
- #1129996
- 124
- North Star Rx #16714088601
Product Specifications
McKesson # | 741858 |
Manufacturer # | 00024582411 |
Brand | Jevtana® |
Manufacturer | Sanofi Pasteur |
Country of Origin | Unknown |
Alternate Manufacturer Number | 1927730 |
Application | Antineoplastic Agent |
Container Type | Single Dose Vial |
Dosage Form | Injection |
Generic Drug Code | 28762 |
Generic Drug Name | Cabazitaxel |
NDC Number | 00024-5824-11 |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
Strength | 60 mg / 1.5 mL |
Type | Intravenous |
UNSPSC Code | 51111728 |
Volume | 1.5 mL |
Features
- JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen
- JEVTANA is supplied as a kit containing one single-use vial of JEVTANA (cabazitaxel) Injection (clear glass vial with a grey rubber closure, aluminum cap and light green plastic flip-off cap) and one vial of Diluent for JEVTANA (13% (w/w) ethanol in water for injection) in a clear glass vial with a grey rubber closure, gold-color aluminum cap and colorless plastic flip-off cap
- JEVTANA requires two dilutions prior to administration
- First diluted solution of JEVTANA should be used immediately (within 30 minutes)
- Fully prepared JEVTANA infusion solution (in either 0.9% sodium chloride solution or 5% dextrose solution) should be used within 8 hours at ambient temperature (including the one-hour infusion), or for a total of 24 hours (including the one-hour infusion) under the refrigerated conditions
- PVC equipment should not be used
More Information
Jevtana® Cabazitaxel 60 mg / 1.5 mL Intravenous Injecti…
